This inventor holds 3 USPTO granted patents. Top assignee: Millennium Pharmaceuticals Limited. Active years: 2002-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2005
Title: The Innovative Contributions of Shengfang Jin
Introduction
Shengfang Jin is a notable inventor based in West Roxbury, MA (US). He has made significant contributions to the field of drug resistance, particularly in cancer research. With a total of 3 patents, his work focuses on identifying and modulating drug-resistant cells.
Latest Patents
One of Shengfang Jin's latest patents is titled "Resistance sequences and uses thereof." This invention highlights that increased expression of resistance sequences is associated with drug resistance in certain cells, such as cancer cells. The methods provided in this patent allow for the identification of drug-resistant cells by measuring the expression or activity of specific resistance genes, including semaphorin D, B94, mel-14 antigen, 24p3, proliferin, and maspin. Additionally, it outlines methods for identifying modulators of drug resistance and for modulating drug resistance itself.
Another significant patent by Shengfang Jin is "Chk1 and uses thereof." This invention also emphasizes that increased expression of Chk1 is linked to drug resistance in certain cells, particularly cancer cells. The patent provides methods for identifying drug-resistant cells by measuring the expression or activity of Chk1. It further includes methods for identifying modulators of drug resistance and for modulating drug resistance through the expression or activity of Chk1.
Career Highlights
Shengfang Jin is currently associated with Millennium Pharmaceuticals Limited, where he continues to advance his research in drug resistance. His work has the potential to significantly impact cancer treatment and improve patient outcomes.
Collaborations
Some of his notable coworkers include Andrew W Shyjan and Mark Williamson, who contribute to the innovative environment at Millennium Pharmaceuticals Limited.
Conclusion
Shengfang Jin's contributions to the field of drug resistance through his patents and research are invaluable. His work not only enhances our understanding of cancer cells but also paves the way for future advancements in treatment strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile